Inhibitors of integrated stress response pathway
Abstract
The present disclosure relates generally to therapeutic agents that may be useful as inhibitors of Integrated Stress Response (ISR) pathway.
Más información
| Fecha de publicación: | 2018 |
| URL: | https://patents.google.com/patent/US20230047589A1/en?assignee=Praxis+biotech&oq=Praxis+biotech |
| DOI: |
US20230047589A1 |